Key result
SARS-CoV-2 infection linked to ~15-fold higher myocarditis incidence, predominantly in men under 50.
Sex differences in COVID-19 and COVID-19 vaccine-associated myocarditis mirror pre-pandemic viral myocarditis—predominantly affecting men under age 50—and appear driven by testosterone-promoted innate immune responses (such as TLR4/IL-1beta signaling in macrophages and mast cells) rather than viral replication alone.
Answers are grounded in this paper and cite their sources.
Supports myocarditis monitoring in young men after infection or mRNA vaccination; hypothesis-generating for sex-specific immune mechanisms.
Myocarditis is frequently caused by viral infections, but animal models that closely resemble human disease suggest that virus-triggered autoimmune disease is the most likely cause of myocarditis. Myocarditis is a rare condition that occurs primarily in men under age 50. The incidence of myocarditis rose at least 15x during the COVID-19 pandemic from 1-10 to 150-400 cases/100,000 individuals, with most cases occurring in men under age 50. COVID-19 vaccination was also associated with rare cases of myocarditis primarily in young men under 50 years of age with an incidence as high as 50 cases/100,000 individuals reported for some mRNA vaccines. Sex differences in the immune response to COVID-19 are virtually identical to the mechanisms known to drive sex differences in myocarditis pre-COVID based on clinical studies and animal models. The many similarities between COVID-19 vaccine-associated myocarditis to COVID-19 myocarditis and non-COVID myocarditis suggest common immune mechanisms drive disease.
No takes yet. Share an insight, caveat, or question.
Beetler et al. (2023) conducted a review in COVID-19 myocarditis and COVID-19 vaccine-associated myocarditis. Male sex, SARS-CoV-2 infection, and COVID-19 mRNA vaccination vs. Female sex and pre-COVID-19 baseline populations was evaluated on Incidence and sex differences in COVID-19 and vaccine-associated myocarditis. SARS-CoV-2 increased myocarditis incidence at least 15-fold (to 150-400/100,000), and mRNA vaccination was linked to up to 50 cases/100,000, both predominantly affecting men under age 50.
Synapse has enriched 10 related papers. Consider them for comparative context: